Contents
- 1 IPO Overview Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
- 1.1 IPO Subscription and Allotment Dates
- 1.2 Share Allocation Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
- 1.3 Financial Metrics Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
- 1.4 Company Profiles of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
- 1.5 Objects of the Issue Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
- 1.6 Peer Comparison Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
- 1.7 Registrars and Lead Managers
- 2 Review Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
- 3 FAQs Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO: The upcoming IPOs of Akums Drugs and Pharmaceuticals Limited and Sanstar Limited offer distinct opportunities for investors. To make an informed decision, it is crucial to understand the key aspects and differences between these two IPOs.
This article provides a detailed comparison, including tables and text to highlight the significant features of each offering.
IPO Overview Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
| Aspect | Akums Drugs and Pharmaceuticals IPO | Sanstar Limited IPO |
|---|---|---|
| IPO Size | ₹1,856.74 crore | ₹510.15 crore |
| New Shares | ₹680 crore from 1 crore new shares | ₹397.10 crore from 4.18 crore new shares |
| Existing Shares (OFS) | ₹113.05 crore from 1.73 crore existing shares | ₹113.05 crore from 1.19 crore existing shares |
| Price Band | ₹646 to ₹679 per share | ₹90 to ₹95 per share |
| Listing Date | August 6, 2024 | July 26, 2024 |
| Lot Size | 22 shares | 150 shares |
| RHP | Akums Drugs and Pharmaceuticals IPO RHP | Sanstar Limited IPO RHP |
Akums Drugs and Pharmaceuticals Limited aims to raise a substantial amount through its IPO, with a price band significantly higher than that of Sanstar Limited. In contrast, Sanstar Limited offers a more affordable entry point for investors.
IPO Subscription and Allotment Dates
| Aspect | Akums Drugs and Pharmaceuticals IPO | Sanstar Limited IPO |
|---|---|---|
| Open Date | July 30, 2024 | July 19, 2024 |
| Close Date | August 1, 2024 | July 23, 2024 |
| Allotment Date | August 2, 2024 | July 24, 2024 |
| Refunds | August 5, 2024 | July 25, 2024 |
| Shares Credit to Demat | August 5, 2024 | July 25, 2024 |
Akums Drugs and Pharmaceuticals has a slightly later timeline for allotment and listing compared to Sanstar Limited. Investors looking for a quicker turn-around might prefer Sanstar’s schedule.
| Category | Akums Drugs and Pharmaceuticals IPO | Sanstar Limited IPO |
|---|---|---|
| Retail Investors | 10% | 35% |
| Qualified Institutional Buyers (QIBs) | 75% | 50% |
| High Net-Worth Individuals (HNIs) | 15% | 15% |
| Employee Discount | ₹64 per share | N/A |
Akums Drugs and Pharmaceuticals offers a smaller portion to retail investors compared to Sanstar Limited, which allocates a more significant percentage of shares to retail investors.
Financial Metrics Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
| Metric | Akums Drugs and Pharmaceuticals Limited | Sanstar Limited |
|---|---|---|
| Revenue (FY 2024) | ₹4,212.21 crore | ₹1,081.68 crore |
| Profit After Tax (PAT) | ₹0.79 crore | ₹66.77 crore |
| Net Worth | ₹709.50 crore | ₹215.91 crore |
| Debt-Equity Ratio | 0.69 | 0.50 |
| EPS | ₹-0.28 | ₹4.75 |
In terms of financial health, Sanstar Limited shows stronger profitability and a more favorable EPS compared to Akums Drugs and Pharmaceuticals. However, Akums Drugs has a larger revenue base.
Company Profiles of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
Akums Drugs and Pharmaceuticals Limited
- Founded: 2004
- Core Services: Contract Development and Manufacturing Organization (CDMO)
- Product Range: Tablets, capsules, injectables, topical preparations, specialized formulations
- Manufacturing Facilities: 10 facilities with an annual production capacity of 49.21 billion units
Akums Drugs and Pharmaceuticals specializes in pharmaceutical manufacturing and development, serving major pharmaceutical companies both in India and internationally.
Sanstar Limited
- Founded: 1982
- Core Products: Plant-based products for food, pet food, and industrial uses
- Manufacturing Sites: Two large facilities in Dhule (Maharashtra) and Kutch (Gujarat)
- Export Markets: 49 countries
Sanstar Limited focuses on producing plant-based products used across various industries, with a significant global presence.
Objects of the Issue Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
| Company | Objects of the Issue |
|---|---|
| Akums Drugs and Pharmaceuticals | Business expansion, debt reduction |
| Sanstar Limited | Expansion of Dhule facility, debt repayment, general corporate purposes |
Akums Drugs and Pharmaceuticals aims to use its IPO proceeds primarily for business expansion and debt reduction. In contrast, Sanstar Limited has a more specific focus on expanding its facilities and managing existing debts.
Peer Comparison Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
| Company | Akums Drugs and Pharmaceuticals Limited | Sanstar Limited |
|---|---|---|
| Peer Group | Divi’s Laboratories, Suven Pharma, Gland Pharma | Gujarat Ambuja Exports, Gulshan Polyols, Sukhjit Starch and Chemicals |
Akums Drugs and Pharmaceuticals is compared to major players in the pharmaceutical manufacturing sector, while Sanstar Limited’s peers are key players in the plant-based product industry.
Registrars and Lead Managers
| Company | Registrar | Lead Managers |
|---|---|---|
| Akums Drugs and Pharmaceuticals | Link Intime India Private Limited | ICICI Securities, Axis Bank, Citigroup Global Markets, Ambit Private Limited |
| Sanstar Limited | Linkintime India Private Limited | Pantomath Capital Advisors Private Limited |
Akums Drugs and Pharmaceuticals has a broader list of lead managers compared to Sanstar Limited, which might indicate a higher level of advisory and underwriting support.
Review Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
Both Akums Drugs and Pharmaceuticals Limited and Sanstar Limited present attractive investment opportunities, though they cater to different sectors and investor preferences. Akums offers a substantial IPO size with a focus on pharmaceutical manufacturing, whereas Sanstar provides a more affordable entry point with a focus on plant-based products.
Investors should consider factors such as company fundamentals, financial performance, IPO size, and market conditions when making their investment decisions. Each IPO has its unique advantages, and the choice between them should align with individual investment strategies and goals.
FAQs Of Akums Drugs and Pharmaceuticals IPO vs. Sanstar Limited IPO
What are the major business activities of each company?
Akums Drugs and Pharmaceuticals Limited: A Contract Development and Manufacturing Organization (CDMO) involved in pharmaceutical product development, manufacturing, and regulatory compliance.
Sanstar Limited: Specializes in manufacturing plant-based products and ingredients for food, pet food, and various industrial uses.
How can investors apply for these IPOs?
Investors can apply for the Akums Drugs and Pharmaceuticals IPO and the Sanstar Limited IPO through their brokers or using the ASBA (Application Supported by Blocked Amount) facility offered by banks.
